|
Advances in Sepsis, SMART™, and SMARTbot™ are supported by educational grants from Eli Lilly and Company, Acute Care. Certain authors and editors may have financial or other relationships with Eli Lilly and Company. Some of the information/data reported here for drugs/devices discussed may differ from information/data contained in the prescribing information approved by regulatory authorities in specific countries. For approved information and uses for drugs/devices discussed, please consult the manufacturer's prescribing information.
 | This activity has been planned and implemented in accordance with the Essential Areas and Policies of ACCME through the joint sponsorship of the University of Kentucky College of Medicine and Remedica. The University of Kentucky College of Medicine is accredited by the ACCME to provide continuing medical education for physicians. The University of Kentucky is an equal opportunity university. |
|